Literature DB >> 1908707

Monoclonal antibodies EBU-141 (CDw75) and EBU-65 allow reliable distinction between mature and pre-B-cell tumors in suspension and on tissue sections.

M Gramatzki1, R Burger, J Kraus, U Lauer, P Rohwer, G Eger, J R Kalden, F Henschke.   

Abstract

Two new monoclonal antibodies, EBU-65 and EBU-141, were raised by immunization with plasma cell line U-266. Both antibodies strongly react with B lymphocytes in immunofluorescent staining as well as on paraffin-embedded sections. More than 200 leukemias and lymphomas were tested, and for both antibodies reactivity was found only with "mature" B-cell tumors but not with precursor B-cell leukemias. None of the non-B-lineage hematolymphatic tumors tested was stained by EBU-141 or EBU-65. A subpopulation of T lymphocytes particularly present in nonmalignant pleural effusions was detected by EBU-65 additionally. Although EBU-141 was clustered as CDw75 and EBU-65 as "unique," a close relationship of the staining pattern was found and both antibodies react with a sialyltransferase. In particular, CDw75 antibody EBU-141 was demonstrated to be very useful for immunophenotyping of B-cell neoplasias, while EBU-65 reacted with most multiple myelomas and a subgroup of "activated"-appearing T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908707     DOI: 10.1007/bf01714956

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  26 in total

1.  Transplantation and cytogenetic studies of Herpesvirus saimiri-induced disease in Marmoset monkeys.

Authors:  B Marczynska; L Falk; L Wolfe; F Deinhardt
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

2.  The regulatory role of sialic acids in the response of class II reactive T cell hybridomas to allogeneic B cells.

Authors:  S Taira; T Kakiuchi; M Minami; H Nariuchi; S Taiara
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1983-05       Impact factor: 3.487

5.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

6.  Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.

Authors:  J Linder; Y Ye; J O Armitage; D D Weisenburger
Journal:  Mod Pathol       Date:  1988-01       Impact factor: 7.842

7.  The comparison of different rosette assay systems for the determination of T-lymphocytes in patients with solid malignant tumors.

Authors:  M Gramatzki; J R Kalden
Journal:  Z Immunitatsforsch Immunobiol       Date:  1978-12

8.  Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.

Authors:  A L Epstein; R J Marder; J N Winter; R I Fox
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

9.  Cryopreserved human cultured T cells as responder cells for the quantitative measurement of interleukin-2: improvement of the assay.

Authors:  M Gramatzki; D M Strong; S B Grove; G D Bonnard
Journal:  J Immunol Methods       Date:  1982-09-17       Impact factor: 2.303

10.  The B cell antigen CD75 is a cell surface sialytransferase.

Authors:  I Stamenkovic; H C Asheim; A Deggerdal; H K Blomhoff; E B Smeland; S Funderud
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  1 in total

1.  Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop.

Authors:  R Burger; J Wendler; K Antoni; G Helm; J R Kalden; M Gramatzki
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.